Singapore’s MerLion eyes partner for Phase III of Finafloxacin urinary infection trials
- 27 January 2015
Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.
Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.